Literature DB >> 18197622

Quantification of free coumarin and its liberation from glucosylated precursors by stable isotope dilution assays based on liquid chromatography-tandem mass spectrometric detection.

Michael Rychlik1.   

Abstract

A stable isotope dilution assay for the quantification of free coumarin and glucosylated coumarin precursors has been developed using [13C2]-coumarin as the internal standard. The doubly labeled coumarin was synthesized by reacting [13C2]-acetic anhydride with salicylic aldehyde and characterized by means of mass spectrometry and nuclear magnetic resonance (NMR) experiments. The specifity of liquid chromatography-tandem mass spectrometry enabled unequivocal determination and sensitive quantitation of the odorant. Because of the very simple extraction procedure, free coumarin could be analyzed within 1h. For quantification of total coumarin, the odorant was liberated from its precursors by an incubation with hydrochloric acid or beta-glucosidase. In analyses of breakfast cereals, the intra-assay coefficient of variation was 9.9% ( n = 5) for total coumarin. When coumarin was added to butter cookies at a level of 10 microg/kg, a recovery of 94.1% was found. Further addition studies revealed a detection limit of 2.9 microg/kg and a quantification limit of 8.6 microg/kg. Application of the stable isotope dilution assay to several plants, foods, and essential oils revealed high contents in cassia products and those foods in which cassia has been used as an ingredient. In contrast to this, Ceylon cinnamon contained much less coumarin. The odorant was also quantified in woodruff, clover seeds, and the essential oils of lavender, citron, and chamomile. Only trace amounts were detected in carrots and the essential oils of peppermint and dill, whereas in bilberries, black raspberries, and Angelica roots, coumarin was below detectable levels. In Ceylon cinnamon and cassia, the odorant occurred mainly in its free form, whereas in fenugreek seeds and woodruff, 68 and 88% of the total coumarin content was liberated from glucosylated precursors, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197622     DOI: 10.1021/jf0728348

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  6 in total

1.  Spectrofluorimetric determination of coumarin in commercial tablets.

Authors:  Mirian Marcolan; Priscila Alfonso Martins; Valber A Pedrosa; Maira R Rodrigues; Hueder P M de Oliveira; Lucia Codognoto
Journal:  J Fluoresc       Date:  2010-11-03       Impact factor: 2.217

2.  Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model.

Authors:  Priyanga Ranasinghe; Sanja Perera; Mangala Gunatilake; Eranga Abeywardene; Nuwan Gunapala; Sirimal Premakumara; Kamal Perera; Dilani Lokuhetty; Prasad Katulanda
Journal:  Pharmacognosy Res       Date:  2012-04

3.  Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial.

Authors:  Priyanga Ranasinghe; Ranil Jayawardena; Shehani Pigera; Wasundara Sevwandi Wathurapatha; Hasitha Dhananjaya Weeratunga; G A Sirimal Premakumara; Prasad Katulanda; Godwin Roger Constantine; Priyadarshani Galappaththy
Journal:  BMC Complement Altern Med       Date:  2017-12-28       Impact factor: 3.659

4.  In Vitro Evaluations of Cytotoxicity of Eight Antidiabetic Medicinal Plants and Their Effect on GLUT4 Translocation.

Authors:  Sleman Kadan; Bashar Saad; Yoel Sasson; Hilal Zaid
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

5.  Anti-proliferative and apoptotic effects of green synthesized silver nanoparticles using Lavandula angustifolia on human glioblastoma cells.

Authors:  Aysel Simsek; Suray Pehlivanoglu; Cigdem Aydin Acar
Journal:  3 Biotech       Date:  2021-07-19       Impact factor: 2.893

6.  Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.

Authors:  Priyanga Ranasinghe; Priyadarshani Galappaththy; Godwin Roger Constantine; Ranil Jayawardena; Hasitha Dhananjaya Weeratunga; Sirimal Premakumara; Prasad Katulanda
Journal:  Trials       Date:  2017-09-29       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.